Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    51,063.61
    -673.94 (-1.30%)
     
  • CMC Crypto 200

    1,329.02
    -67.51 (-4.84%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

These Coronavirus Vaccine Makers Are Winning the Money Game So Far

These Coronavirus Vaccine Makers Are Winning the Money Game So Far

It's difficult if not impossible to accurately assess which novel coronavirus vaccine candidates in clinical testing are likely to be the safest and most effective. For the most part, all we have to go on at this point are preliminary results from early-stage clinical studies. Sanofi (NASDAQ: SNY) and GlaxoSmithKline (NYSE: GSK) take the top honors.